Clinical Trial Update: A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy Europeans Children Aged 6 to 35 Months [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a swine-origin A/H1N1 influenza vaccine in healthy European children aged 6 to 35 months has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Swine-origin Influenza

Drugs mentioned

• Sanofi Pasteur Swine-origin A/H1N1 influenza vaccine (influenza vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Influenza, Swine-origin A/H1N1 Influenza | Phase 2 | Status: COMPLETED